Henry Schein (NASDAQ:HSIC) Stock Acquired Rep. Robert Bresnahan, Jr.

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Henry Schein, Inc. NASDAQ: HSIC. In a filing disclosed on May 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in Henry Schein stock on April 8th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 4/17/2025.
• Sold $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 4/16/2025.
• Sold $1,001 - $15,000 in shares of Western Digital NASDAQ: WDC on 4/11/2025.
• Purchased $1,001 - $15,000 in shares of Alphabet NASDAQ: GOOG on 4/11/2025.
• Purchased $1,001 - $15,000 in shares of Texas Instruments NASDAQ: TXN on 4/11/2025.
• Purchased $1,001 - $15,000 in shares of NVIDIA NASDAQ: NVDA on 4/11/2025.
• Sold $1,001 - $15,000 in shares of Western Digital NASDAQ: WDC on 4/10/2025.
• Sold $1,001 - $15,000 in shares of DexCom NASDAQ: DXCM on 4/8/2025.
• Sold $1,001 - $15,000 in shares of Invesco NYSE: IVZ on 4/8/2025.
• Sold $1,001 - $15,000 in shares of Generac NYSE: GNRC on 4/8/2025.

Henry Schein Price Performance

Shares of NASDAQ:HSIC traded down $0.40 during midday trading on Wednesday, hitting $70.14. The company's stock had a trading volume of 319,898 shares, compared to its average volume of 1,634,029. The company has a market cap of $8.54 billion, a P/E ratio of 28.85, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The business's 50 day simple moving average is $67.52 and its 200 day simple moving average is $71.45. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business's revenue was down .1% on a year-over-year basis. During the same period last year, the company posted $1.10 EPS. On average, analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Insiders Place Their Bets

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. The trade was a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. The trade was a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.08% of the company's stock.

Analyst Upgrades and Downgrades

HSIC has been the topic of several recent research reports. Piper Sandler lowered their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. StockNews.com downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Wells Fargo & Company decreased their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. UBS Group cut their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Finally, Jefferies Financial Group upped their price objective on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Henry Schein presently has a consensus rating of "Moderate Buy" and a consensus price target of $79.30.

Hedge Funds Weigh In On Henry Schein

Hedge funds have recently made changes to their positions in the stock. JPMorgan Chase & Co. lifted its stake in Henry Schein by 6.5% during the first quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company's stock worth $436,489,000 after purchasing an additional 390,399 shares in the last quarter. Invesco Ltd. lifted its stake in Henry Schein by 0.4% during the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock worth $343,468,000 after acquiring an additional 17,552 shares in the last quarter. FMR LLC lifted its stake in Henry Schein by 6.6% during the 4th quarter. FMR LLC now owns 3,498,033 shares of the company's stock worth $242,064,000 after acquiring an additional 217,143 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Henry Schein by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock valued at $218,762,000 after acquiring an additional 14,876 shares during the period. Finally, Palestra Capital Management LLC acquired a new position in Henry Schein in the 4th quarter valued at about $182,988,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election. Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.